This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
OMNIPAQUE 240
GE HEALTHCARE CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of OMNIPAQUE 240 in Canada?
A shortage of OMNIPAQUE 240 518MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 9, 2026), but it has not started yet.
When will OMNIPAQUE 240 be available again?
The manufacturer's estimated resolution date is November 11, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02172739
Strength
518MG
Dosage Form
SOLUTION
Route
INTRAVASCULAR SUBARACHNOIDAL
Active Ingredient
IOHEXOL
Tier
Unrated
Last Updated
2023-01-25
Reason for Shortage
Shortage of an inactive ingredient or component.
Past Reports for This Drug
OMNIPAQUE 240 has 6 shortage/discontinuation reports on file — this is one of them.
Other Products from GE HEALTHCARE CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.